CORDIS · 101096473 · HORIZON

LUCIA Understanding Lung Cancer related risk factors and their Impact

Coordinator: TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY (IL)

Lung Cancer (LC) is the biggest cancer killer worldwide, with five-year survival following diagnosis varying between 5% to 25%. Though tobacco smoking has long been recognized as the major risk factor for LC, many cases (incl. LC patients that are non-smokers) cannot be explained by this reason. In this sense, LUCIA aims to establish a novel toolbox for discovering and understanding new risk factors that contribute to LC development. The toolbox encompasses the analysis of three aspects: (i) personal risk factors, which include a person’s exposure to chemical pollutants and behavioural and li…

EU contribution
€13.5M
Total cost
€13.5M
Period
2023-01-01 → 2026-12-31
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-RIA
Call
HORIZON-MISS-2021-CANCER-02
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

EU contribution: €13.5M awarded to the consortium. The project runs over approximately 4 years from 2023-01-01 to 2026-12-31.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-RIA funding scheme.
What is the EU contribution?
The European Commission contributes €13.5M toward a total project budget of €13.5M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-MISS-2021-CANCER-02.
Who coordinates the project?
The project is coordinated by TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY (IL).
What is the project timeline?
The project runs from 2023-01-01 to 2026-12-31 — approximately 4 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101096473.